Stryker | SYK - Ebit

Stock Price
329.01
Daily Change
1.50 0.46%
Monthly
0.89%
Yearly
-10.23%
Q2 Forecast
320.50

Stryker reported $1.97B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.05B 190M Mar/2026
CONMED USD 36.62M 24.74M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Danaher USD 1.34B 158M Mar/2026
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 13.71M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.51B Mar/2026
Masimo USD 83.9M 200K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Olympus JPY 28B 5.56B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 76.31M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025